Esteban Cugat Andorrà
Esteban Cugat Andorrà publishes mostly in Surgery, Oncology and Pulmonary and Respiratory Medicine, on topics such as Pancreatic and Hepatic Oncology Research, Hepatocellular Carcinoma Treatment and Prognosis and Gallbladder and Bile Duct Disorders.
- World rank
- #7,153,951 of 7,710,434 ranked researchers
- Rank in Spain
- #182,613 of 204,306
- Works
- 108
- Citations
- 291
- Citations per work
- 2.7
What does Esteban Cugat Andorrà research?
Esteban Cugat Andorrà's work is mostly in Medicine (86%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences9385.8%
- Medicine9385.8%
- Everything else1514.2%
- 1Surgery33% of their works
- 2Oncology20% of their works
- 3Pulmonary and Respiratory Medicine15% of their works
- 4Hepatology11% of their works
- 5Gastroenterology3% of their works
- 6Epidemiology3% of their works
Research topics
- Pancreatic and Hepatic Oncology Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Gallbladder and Bile Duct Disorders
- Pancreatitis Pathology and Treatment
- Minimally Invasive Surgical Techniques
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gastrointestinal Tumor Research and Treatment
- Renal cell carcinoma treatment
Which keywords describe Esteban Cugat Andorrà's research?
The keywords of their largest research topics: Immunotherapy, Pancreatic Cancer, Surgical Complications, Treatment, Cholangiocarcinoma, Epidemiology, Hepatocellular Carcinoma and Liver Cancer.
- Renal Cell Carcinoma
- Sunitinib
- Intrahepatic Cholangiocarcinoma
- Transgastric Surgery
- Chronic Pancreatitis
- Surgical Management
- Cholecystitis
- Liver Cancer
- Epidemiology
- Treatment
- Pancreatic Cancer
- Immunotherapy
- Surgical Complications
- Cholangiocarcinoma
- Hepatocellular Carcinoma
- Prognostic Factors
- ERCP
- Acute Pancreatitis
- Single-Incision Laparoscopy
- Biliary Tract Cancer
- Imatinib Mesylate
- Metastatic
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Immunotherapy542 topics
- Pancreatic Cancer471 topic
- Surgical Complications471 topic
- Treatment352 topics
- Cholangiocarcinoma332 topics
- Epidemiology282 topics
- Hepatocellular Carcinoma281 topic
- Liver Cancer281 topic
- Prognostic Factors273 topics
- Cholecystitis211 topic
- ERCP211 topic
- Surgical Management202 topics
- Acute Pancreatitis161 topic
- Chronic Pancreatitis161 topic
- Single-Incision Laparoscopy151 topic
- Transgastric Surgery151 topic
- Biliary Tract Cancer121 topic
- Intrahepatic Cholangiocarcinoma121 topic
- Imatinib Mesylate81 topic
- Sunitinib81 topic
- Metastatic71 topic
- Renal Cell Carcinoma71 topic
Where does Esteban Cugat Andorrà work?
Esteban Cugat Andorrà's main affiliation in the publication record is Mútua Terrassa, Spain.
How many publications and citations does Esteban Cugat Andorrà have?
OpenAlex counts 108 works and 291 citations for Esteban Cugat Andorrà, an h-index of 9, ranking #7,153,951 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Esteban Cugat Andorrà. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.